[Drug-induced cholestasis].
Searashi
Yasuyuki
Y
Division of Gastroenterology and Hepatology, Jikei University School of Medicine.
Matsudaira
Hiroshi
H
Takagi
Ichiro
I
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002746:Chlorpromazine / Q000009:adverse effects*; D002779:Cholestasis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D004365:Drugs, Chinese Herbal / Q000009:adverse effects; D004917:Erythromycin / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D010406:Penicillins / Q000009:adverse effects; D013420:Sulfamethoxazole / Q000009:adverse effects; D045165:Testosterone Congeners / Q000009:adverse effects; D014295:Trimethoprim / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000970:Antineoplastic Agents; D014150:Antipsychotic Agents; D004365:Drugs, Chinese Herbal; D007166:Immunosuppressive Agents; D010406:Penicillins; D045165:Testosterone Congeners; D004917:Erythromycin; D014295:Trimethoprim; D013420:Sulfamethoxazole; D002746:Chlorpromazine